According to Raymond James, the prior rating for AeroVironment Inc (NASDAQ:AVAV) was changed from Outperform to Strong Buy. For the third quarter, AeroVironment had an EPS of $0.33, compared to year-ago quarter EPS of $0.32. The current stock performance of AeroVironment shows a 52-week-high of $114.07 and a 52-week-low of $70.08. Moreover, at the end of the last trading period, the closing price was at $91.95.

For Health Catalyst Inc (NASDAQ:HCAT), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the fourth quarter, Health Catalyst showed an EPS of $0.05, compared to $0.19 from the year-ago quarter. The current stock performance of Health Catalyst shows a 52-week-high of $27.98 and a 52-week-low of $6.41. Moreover, at the end of the last trading period, the closing price was at $11.87.

For ServiceNow Inc (NYSE:NOW), Baird upgraded the previous rating of Neutral to Outperform. In the fourth quarter, ServiceNow showed an EPS of $2.28, compared to $1.46 from the year-ago quarter. The current stock performance of ServiceNow shows a 52-week-high of $575.64 and a 52-week-low of $337.05. Moreover, at the end of the last trading period, the closing price was at $464.49.

JP Morgan upgraded the previous rating for Prudential Financial Inc (NYSE:PRU) from Neutral to Overweight. In the fourth quarter, Prudential Financial showed an EPS of $2.42, compared to $3.18 from the year-ago quarter. The stock has a 52-week-high of $122.54 and a 52-week-low of $75.37. At the end of the last trading period, Prudential Financial closed at $82.43.

According to Goldman Sachs, the prior rating for Corebridge Financial Inc (NYSE:CRBG) was changed from Neutral to Buy. Corebridge Financial earned $0.88 in the fourth quarter, compared to $1.13 in the year-ago quarter. The stock has a 52-week-high of $23.49 and a 52-week-low of $14.01. At the end of the last trading period, Corebridge Financial closed at $15.56.

For Oncternal Therapeutics Inc (NASDAQ:ONCT), Maxim Group downgraded the previous rating of Buy to Hold. For the fourth quarter, Oncternal Therapeutics had an EPS of $0.20, compared to year-ago quarter EPS of $0.16. The current stock performance of Oncternal Therapeutics shows a 52-week-high of $1.85 and a 52-week-low of $0.60. Moreover, at the end of the last trading period, the closing price was at $0.79.

According to Brookline Capital, the prior rating for Oncternal Therapeutics Inc (NASDAQ:ONCT) was changed from Buy to Hold. For the fourth quarter, Oncternal Therapeutics had an EPS of $0.20, compared to year-ago quarter EPS of $0.16. The current stock performance of Oncternal Therapeutics shows a 52-week-high of $1.85 and a 52-week-low of $0.60. Moreover, at the end of the last trading period, the closing price was at $0.79.

According to SVB Leerink, the prior rating for Pardes Biosciences Inc (NASDAQ:PRDS) was changed from Outperform to Market Perform. Pardes Biosciences earned $0.41 in the fourth quarter, compared to $0.56 in the year-ago quarter. The current stock performance of Pardes Biosciences shows a 52-week-high of $8.75 and a 52-week-low of $0.80. Moreover, at the end of the last trading period, the closing price was at $1.43.

Maxim Group downgraded the previous rating for Recruiter.Com Group Inc (NASDAQ:RCRT) from Buy to Hold. For the fourth quarter, Recruiter.Com Group had an EPS of $0.48, compared to year-ago quarter EPS of $0.33. The current stock performance of Recruiter.Com Group shows a 52-week-high of $2.75 and a 52-week-low of $0.20. Moreover, at the end of the last trading period, the closing price was at $0.25.

Benchmark downgraded the previous rating for World Wrestling Entertainment Inc (NYSE:WWE) from Buy to Hold. In the fourth quarter, World Wrestling Enter showed an EPS of $0.52, compared to $0.70 from the year-ago quarter. The current stock performance of World Wrestling Enter shows a 52-week-high of $93.63 and a 52-week-low of $55.13. Moreover, at the end of the last trading period, the closing price was at $89.30.

For Certara Inc (NASDAQ:CERT), Barclays downgraded the previous rating of Overweight to Equal-Weight. For the fourth quarter, Certara had an EPS of $0.16, compared to year-ago quarter EPS of $0.01. The current stock performance of Certara shows a 52-week-high of $24.83 and a 52-week-low of $10.61. Moreover, at the end of the last trading period, the closing price was at $23.57.

According to Barclays, the prior rating for Catalent Inc (NYSE:CTLT) was changed from Overweight to Equal-Weight. For the second quarter, Catalent had an EPS of $0.67, compared to year-ago quarter EPS of $0.90. The current stock performance of Catalent shows a 52-week-high of $115.30 and a 52-week-low of $40.70. Moreover, at the end of the last trading period, the closing price was at $62.92.

B of A Securities downgraded the previous rating for Stem Inc (NYSE:STEM) from Neutral to Underperform. Stem earned $0.23 in the fourth quarter, compared to $0.23 in the year-ago quarter. The current stock performance of Stem shows a 52-week-high of $18.01 and a 52-week-low of $4.67. Moreover, at the end of the last trading period, the closing price was at $5.91.

Mizuho downgraded the previous rating for Idacorp Inc (NYSE:IDA) from Buy to Neutral. For the fourth quarter, Idacorp had an EPS of $0.83, compared to year-ago quarter EPS of $0.65. The current stock performance of Idacorp shows a 52-week-high of $118.92 and a 52-week-low of $93.53. Moreover, at the end of the last trading period, the closing price was at $108.03.

HC Wainwright & Co. downgraded the previous rating for Oncternal Therapeutics Inc (NASDAQ:ONCT) from Buy to Neutral. Oncternal Therapeutics earned $0.20 in the fourth quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Oncternal Therapeutics shows a 52-week-high of $1.85 and a 52-week-low of $0.60. Moreover, at the end of the last trading period, the closing price was at $0.79.

Morgan Stanley downgraded the previous rating for Ascendis Pharma A/S (NASDAQ:ASND) from Overweight to Equal-Weight. For the fourth quarter, Ascendis Pharma had an EPS of $3.78, compared to year-ago quarter EPS of $2.14. At the moment, the stock has a 52-week-high of $134.48 and a 52-week-low of $61.95. Ascendis Pharma closed at $72.83 at the end of the last trading period.

Morgan Stanley downgraded the previous rating for Ncino Inc (NASDAQ:NCNO) from Overweight to Equal-Weight. For the fourth quarter, Ncino had an EPS of $0.04, compared to year-ago quarter EPS of $0.09. The current stock performance of Ncino shows a 52-week-high of $47.82 and a 52-week-low of $19.58. Moreover, at the end of the last trading period, the closing price was at $24.44.

According to Oppenheimer, the prior rating for Oncternal Therapeutics Inc (NASDAQ:ONCT) was changed from Outperform to Perform. For the fourth quarter, Oncternal Therapeutics had an EPS of $0.20, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $1.85 and a 52-week-low of $0.60. At the end of the last trading period, Oncternal Therapeutics closed at $0.79.

Keybanc downgraded the previous rating for Charter Communications Inc (NASDAQ:CHTR) from Overweight to Sector Weight. Charter Communications earned $7.69 in the fourth quarter, compared to $8.93 in the year-ago quarter. The current stock performance of Charter Communications shows a 52-week-high of $574.65 and a 52-week-low of $297.83. Moreover, at the end of the last trading period, the closing price was at $356.21.

William Blair initiated coverage on Paycor HCM Inc (NASDAQ:PYCR) with a Market Perform rating. In the second quarter, Paycor HCM showed an EPS of $0.08, compared to $0.05 from the year-ago quarter. The current stock performance of Paycor HCM shows a 52-week-high of $34.75 and a 52-week-low of $20.14. Moreover, at the end of the last trading period, the closing price was at $26.01.

Stephens & Co. initiated coverage on Ameris Bancorp (NASDAQ:ABCB) with a Equal-Weight rating. The price target for Ameris is set to $41.00. In the fourth quarter, Ameris showed an EPS of $1.17, compared to $1.17 from the year-ago quarter. The stock has a 52-week-high of $54.17 and a 52-week-low of $34.28. At the end of the last trading period, Ameris closed at $35.99.

With an Overweight rating, Cantor Fitzgerald initiated coverage on CSG Systems International Inc (NASDAQ:CSGS). The price target seems to have been set at $65.00 for CSG Systems Intl. For the fourth quarter, CSG Systems Intl had an EPS of $0.84, compared to year-ago quarter EPS of $0.83. The current stock performance of CSG Systems Intl shows a 52-week-high of $65.95 and a 52-week-low of $49.02. Moreover, at the end of the last trading period, the closing price was at $53.84.

Citigroup initiated coverage on Sarepta Therapeutics Inc (NASDAQ:SRPT) with a Buy rating. The price target for Sarepta Therapeutics is set to $179.00. For the fourth quarter, Sarepta Therapeutics had an EPS of $0.53, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $159.84 and a 52-week-low of $61.30. Sarepta Therapeutics closed at $137.55 at the end of the last trading period.

With an Overweight rating, Piper Sandler initiated coverage on Corcept Therapeutics Inc (NASDAQ:CORT). The price target seems to have been set at $27.00 for Corcept Therapeutics. In the fourth quarter, Corcept Therapeutics showed an EPS of $0.14, compared to $0.35 from the year-ago quarter. The current stock performance of Corcept Therapeutics shows a 52-week-high of $30.13 and a 52-week-low of $17.19. Moreover, at the end of the last trading period, the closing price was at $22.51.

Stephens & Co. initiated coverage on United Bankshares Inc (NASDAQ:UBSI) with a Equal-Weight rating. The price target for United Bankshares is set to $32.00. United Bankshares earned $0.74 in the fourth quarter, compared to $0.56 in the year-ago quarter. The current stock performance of United Bankshares shows a 52-week-high of $44.15 and a 52-week-low of $33.11. Moreover, at the end of the last trading period, the closing price was at $34.90.

With a Equal-Weight rating, Stephens & Co. initiated coverage on City Holding Co (NASDAQ:CHCO). The price target seems to have been set at $89.00 for City Holding. For the fourth quarter, City Holding had an EPS of $2.05, compared to year-ago quarter EPS of $1.54. The current stock performance of City Holding shows a 52-week-high of $102.94 and a 52-week-low of $73.50. Moreover, at the end of the last trading period, the closing price was at $89.98.

With a Equal-Weight rating, Stephens & Co. initiated coverage on Wesbanco Inc (NASDAQ:WSBC). The price target seems to have been set at $28.00 for Wesbanco. For the fourth quarter, Wesbanco had an EPS of $0.84, compared to year-ago quarter EPS of $0.82. At the moment, the stock has a 52-week-high of $41.37 and a 52-week-low of $29.61. Wesbanco closed at $30.71 at the end of the last trading period.

With a Equal-Weight rating, Stephens & Co. initiated coverage on Sandy Spring Bancorp Inc (NASDAQ:SASR). The price target seems to have been set at $28.00 for Sandy Spring Bancorp. In the fourth quarter, Sandy Spring Bancorp showed an EPS of $0.79, compared to $1.05 from the year-ago quarter. The stock has a 52-week-high of $45.42 and a 52-week-low of $25.34. At the end of the last trading period, Sandy Spring Bancorp closed at $25.53.

With an Overweight rating, Stephens & Co. initiated coverage on Primis Financial Corp (NASDAQ:FRST). The price target seems to have been set at $13.00 for Primis Finl. For the fourth quarter, Primis Finl had an EPS of $0.12, compared to year-ago quarter EPS of $0.31. The current stock performance of Primis Finl shows a 52-week-high of $14.39 and a 52-week-low of $9.35. Moreover, at the end of the last trading period, the closing price was at $9.55.

Stephens & Co. initiated coverage on WSFS Financial Corp (NASDAQ:WSFS) with an Overweight rating. The price target for WSFS Financial is set to $47.00. WSFS Financial earned $1.38 in the fourth quarter, compared to $1.04 in the year-ago quarter. The current stock performance of WSFS Financial shows a 52-week-high of $51.77 and a 52-week-low of $34.83. Moreover, at the end of the last trading period, the closing price was at $37.40.

Stephens & Co. initiated coverage on F N B Corp (NYSE:FNB) with an Overweight rating. The price target for F N B is set to $15.00. In the fourth quarter, F N B showed an EPS of $0.44, compared to $0.30 from the year-ago quarter. The current stock performance of F N B shows a 52-week-high of $14.71 and a 52-week-low of $10.48. Moreover, at the end of the last trading period, the closing price was at $11.41.

With an Overweight rating, Stephens & Co. initiated coverage on United Community Banks Inc (NASDAQ:UCBI). The price target seems to have been set at $34.00 for United Community Banks. United Community Banks earned $0.75 in the fourth quarter, compared to $0.64 in the year-ago quarter. The current stock performance of United Community Banks shows a 52-week-high of $39.48 and a 52-week-low of $25.13. Moreover, at the end of the last trading period, the closing price was at $27.89.

Raymond James initiated coverage on Franklin BSP Realty Trust Inc (NYSE:FBRT) with an Outperform rating. The price target for Franklin BSP Realty Trust is set to $13.50. For the fourth quarter, Franklin BSP Realty Trust had an EPS of $0.37, compared to year-ago quarter EPS of $0.36. The stock has a 52-week-high of $16.17 and a 52-week-low of $10.36. At the end of the last trading period, Franklin BSP Realty Trust closed at $11.96.

With a Buy rating, Stifel initiated coverage on Fastenal Co (NASDAQ:FAST). The price target seems to have been set at $61.00 for Fastenal. Fastenal earned $0.43 in the fourth quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $60.72 and a 52-week-low of $43.74. Fastenal closed at $53.83 at the end of the last trading period.